ORGANIZATION
Former Benesis GMP Violation: Ueda Vows to “Root Out” Problems in JBPO
In an interview with Jiho on October 17, Hidehiko Ueda, president of the Japan Blood Products Organization (JBPO), expressed his determination to strive to “root out” problems within the organization to prevent the recurrence of Good Manufacturing Practice (GMP) violations.…
To read the full story
ORGANIZATION
- EFPIA Report Calls Japan a “Cautionary Tale” in 10-Country Biopharma Strategy Review
March 2, 2026
- Pharma Takes Harsh View of FY2026 Pricing Reform: Policy Group Survey
February 24, 2026
- JPMA to Push Govt to Scrap Market-Based Drug Price Revisions
February 20, 2026
- Pharma Group Looks to Growth Strategy under Takaichi after Election Win
February 10, 2026
- Pharma Groups Call for Faster Diagnosis and R&D for Intractable, Rare Diseases
February 9, 2026
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…





